Publikation:

Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test battery

Lade...
Vorschaubild

Dateien

Zimmer_0-266315.pdf
Zimmer_0-266315.pdfGröße: 4.33 MBDownloads: 256

Datum

2014

Autor:innen

Foerster, Sunniva
Westerhout, Joost
Julien, Sylvie
Krause, Karl-Heinz
van Thriel, Christoph
Hengstler, Jan G.

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

ArXiv-ID

Internationale Patentnummer

Angaben zur Forschungsförderung

Projekt

Open Access-Veröffentlichung
Open Access Gold
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published

Erschienen in

Archives of Toxicology. 2014, 88(5), pp. 1109-1126. ISSN 0340-5761. eISSN 1432-0738. Available under: doi: 10.1007/s00204-014-1231-9

Zusammenfassung

Developmental toxicity in vitro assays have hitherto been established as stand-alone systems, based on a limited number of toxicants. Within the embryonic stem cell-based novel alternative tests project, we developed a test battery framework that allows inclusion of any developmental toxicity assay and that explores the responses of such test systems to a wide range of drug-like compounds. We selected 28 compounds, including several biologics (e.g., erythropoietin), classical pharmaceuticals (e.g., roflumilast) and also six environmental toxicants. The chemical, toxicological and clinical data of this screen library were compiled. In order to determine a non-cytotoxic concentration range, cytotoxicity data were obtained for all compounds from HEK293 cells and from murine embryonic stem cells. Moreover, an estimate of relevant exposures was provided by literature data mining. To evaluate feasibility of the suggested test framework, we selected a well-characterized assay that evaluates ‘migration inhibition of neural crest cells.’ Screening at the highest non-cytotoxic concentration resulted in 11 hits (e.g., geldanamycin, abiraterone, gefitinib, chlorpromazine, cyproconazole, arsenite). These were confirmed in concentration–response studies. Subsequent pharmacokinetic modeling indicated that triadimefon exerted its effects at concentrations relevant to the in vivo situation, and also interferon-β and polybrominated diphenyl ether showed effects within the same order of magnitude of concentrations that may be reached in humans. In conclusion, the test battery framework can identify compounds that disturb processes relevant for human development and therefore may represent developmental toxicants. The open structure of the strategy allows rich information to be generated on both the underlying library, and on any contributing assay.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
570 Biowissenschaften, Biologie

Schlagwörter

Test battery-based compound screening, Developmental toxicity testing, hESC-based test system, Neural crest migration assay

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690ZIMMER, Bastian, Giorgia PALLOCCA, Nadine DRESER, Sunniva FOERSTER, Tanja WALDMANN, Joost WESTERHOUT, Sylvie JULIEN, Karl-Heinz KRAUSE, Christoph VAN THRIEL, Jan G. HENGSTLER, Agapios SACHINIDIS, Sieto BOSGRA, Marcel LEIST, 2014. Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test battery. In: Archives of Toxicology. 2014, 88(5), pp. 1109-1126. ISSN 0340-5761. eISSN 1432-0738. Available under: doi: 10.1007/s00204-014-1231-9
BibTex
@article{Zimmer2014Profi-29451,
  year={2014},
  doi={10.1007/s00204-014-1231-9},
  title={Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test battery},
  number={5},
  volume={88},
  issn={0340-5761},
  journal={Archives of Toxicology},
  pages={1109--1126},
  author={Zimmer, Bastian and Pallocca, Giorgia and Dreser, Nadine and Foerster, Sunniva and Waldmann, Tanja and Westerhout, Joost and Julien, Sylvie and Krause, Karl-Heinz and van Thriel, Christoph and Hengstler, Jan G. and Sachinidis, Agapios and Bosgra, Sieto and Leist, Marcel}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29451">
    <dcterms:title>Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test battery</dcterms:title>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-12-17T13:18:16Z</dc:date>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/29451/3/Zimmer_0-266315.pdf"/>
    <dcterms:issued>2014</dcterms:issued>
    <dc:creator>Zimmer, Bastian</dc:creator>
    <dc:creator>Leist, Marcel</dc:creator>
    <dc:creator>Westerhout, Joost</dc:creator>
    <dc:contributor>Waldmann, Tanja</dc:contributor>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:contributor>Hengstler, Jan G.</dc:contributor>
    <dc:contributor>Julien, Sylvie</dc:contributor>
    <dc:creator>Krause, Karl-Heinz</dc:creator>
    <dc:creator>Dreser, Nadine</dc:creator>
    <dc:contributor>Krause, Karl-Heinz</dc:contributor>
    <dc:contributor>van Thriel, Christoph</dc:contributor>
    <dc:creator>Foerster, Sunniva</dc:creator>
    <dc:contributor>Bosgra, Sieto</dc:contributor>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:creator>Bosgra, Sieto</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/29451/3/Zimmer_0-266315.pdf"/>
    <dc:contributor>Leist, Marcel</dc:contributor>
    <dc:creator>Waldmann, Tanja</dc:creator>
    <dc:contributor>Westerhout, Joost</dc:contributor>
    <dc:contributor>Sachinidis, Agapios</dc:contributor>
    <dc:rights>terms-of-use</dc:rights>
    <dc:contributor>Pallocca, Giorgia</dc:contributor>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Sachinidis, Agapios</dc:creator>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/29451"/>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-12-17T13:18:16Z</dcterms:available>
    <dcterms:abstract xml:lang="eng">Developmental toxicity in vitro assays have hitherto been established as stand-alone systems, based on a limited number of toxicants. Within the embryonic stem cell-based novel alternative tests project, we developed a test battery framework that allows inclusion of any developmental toxicity assay and that explores the responses of such test systems to a wide range of drug-like compounds. We selected 28 compounds, including several biologics (e.g., erythropoietin), classical pharmaceuticals (e.g., roflumilast) and also six environmental toxicants. The chemical, toxicological and clinical data of this screen library were compiled. In order to determine a non-cytotoxic concentration range, cytotoxicity data were obtained for all compounds from HEK293 cells and from murine embryonic stem cells. Moreover, an estimate of relevant exposures was provided by literature data mining. To evaluate feasibility of the suggested test framework, we selected a well-characterized assay that evaluates ‘migration inhibition of neural crest cells.’ Screening at the highest non-cytotoxic concentration resulted in 11 hits (e.g., geldanamycin, abiraterone, gefitinib, chlorpromazine, cyproconazole, arsenite). These were confirmed in concentration–response studies. Subsequent pharmacokinetic modeling indicated that triadimefon exerted its effects at concentrations relevant to the in vivo situation, and also interferon-β and polybrominated diphenyl ether showed effects within the same order of magnitude of concentrations that may be reached in humans. In conclusion, the test battery framework can identify compounds that disturb processes relevant for human development and therefore may represent developmental toxicants. The open structure of the strategy allows rich information to be generated on both the underlying library, and on any contributing assay.</dcterms:abstract>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:contributor>Zimmer, Bastian</dc:contributor>
    <dc:contributor>Dreser, Nadine</dc:contributor>
    <dc:language>eng</dc:language>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Hengstler, Jan G.</dc:creator>
    <dc:creator>Pallocca, Giorgia</dc:creator>
    <dc:creator>van Thriel, Christoph</dc:creator>
    <dc:creator>Julien, Sylvie</dc:creator>
    <dc:contributor>Foerster, Sunniva</dc:contributor>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Diese Publikation teilen